M. Azzi, C. Betancur, I. Sillaber, C. Spanagel, W. Rostène et al., Repeated Administration of the Neurotensin Receptor Antagonist SR 48692 Differentially Regulates Mesocortical and Mesolimbic Dopaminergic Systems, Journal of Neurochemistry, vol.71, issue.3, pp.1158-1167, 1998.
DOI : 10.1046/j.1471-4159.1998.71031158.x

D. Baker, R. Fuchs, S. Specio, T. Khroyan, and J. Neisewander, Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference, Synapse, vol.50, issue.2, pp.181-193, 1998.
DOI : 10.1002/(SICI)1098-2396(199810)30:2<181::AID-SYN8>3.0.CO;2-8

M. Baptista, R. Martin-fardon, and F. Weiss, Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer, Journal of Neuroscience, vol.24, issue.20, pp.4723-4727, 2004.
DOI : 10.1523/JNEUROSCI.0176-04.2004

M. Bardo and R. Bevins, Conditioned place preference: what does it add to our preclinical understanding of drug reward?, Psychopharmacology, vol.153, issue.1, pp.31-43, 2000.
DOI : 10.1007/s002130000569

E. Bartlett, B. Chapman, E. Hallin, and B. Angrist, Selective Sensitization to the Psychosis-Inducing Effects of Cocaine: A Possible Marker for Addiction Relapse Vulnerability?, Neuropsychopharmacology, vol.16, issue.1, pp.77-82, 1997.
DOI : 10.1016/S0893-133X(96)00164-9

M. Beinfeld, What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization, Life Sciences, vol.73, issue.6, pp.643-654, 2003.
DOI : 10.1016/S0024-3205(03)00384-9

A. Bérod and W. Rostène, Neurotensin: an endogenous psychostimulant?, Current Opinion in Pharmacology, vol.2, issue.1, pp.93-98, 2002.
DOI : 10.1016/S1471-4892(01)00127-8

C. Betancur, R. Cabrera, R. De-kloet, D. Pélaprat, and W. Rostène, Role of endogenous neurotensin in the behavior and neuroendocrine effects of cocaine, 1998.

E. Binder, B. Kinkead, M. Owens, and C. Nemeroff, Neurotensin and dopamine interactions, Pharmacol Rev, vol.53, pp.453-486, 2001.

A. Blackburn, K. Dewar, P. Bauco, and P. Rompre, Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation, Brain Research, vol.998, issue.2, pp.184-193, 2004.
DOI : 10.1016/j.brainres.2003.11.022

S. Borgland, R. Malenka, and A. Bonci, Acute and Chronic Cocaine-Induced Potentiation of Synaptic Strength in the Ventral Tegmental Area: Electrophysiological and Behavioral Correlates in Individual Rats, Journal of Neuroscience, vol.24, issue.34, pp.7482-7490, 2004.
DOI : 10.1523/JNEUROSCI.1312-04.2004

H. Boudin, D. Pélaprat, W. Rostène, and A. Beaudet, Cellular distribution of neurotensin receptors in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor, The Journal of Comparative Neurology, vol.206, issue.1, pp.76-89, 1996.
DOI : 10.1002/(SICI)1096-9861(19960909)373:1<76::AID-CNE7>3.0.CO;2-A

R. Carraway and S. Leeman, The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus, J Biol Chem, vol.248, pp.6854-6861, 1973.

F. Costa, R. Frussa-filho, and L. Felicio, The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice, European Journal of Pharmacology, vol.428, issue.1, pp.97-103, 2001.
DOI : 10.1016/S0014-2999(01)01271-7

H. Crombag, A. Badiani, J. Chan, J. Dell-'orco, S. Dineen et al., The Ability of Environmental Context to Facilitate Psychomotor Sensitization to Amphetamine Can Be Dissociated from Its Effect on Acute Drug Responsiveness and on Conditioned Responding, Neuropsychopharmacology, vol.24, issue.6, pp.680-690, 2001.
DOI : 10.1016/S0893-133X(00)00238-4

D. Lima, M. De-oliveira-soares, B. Reisser, A. Farrell, and M. , Pharmacological treatment of cocaine dependence: a systematic review, Addiction, vol.17, issue.8, pp.931-949, 2002.
DOI : 10.1046/j.1360-0443.2002.00209.x

D. Vries, T. Shaham, Y. Homberg, J. Crombag, H. Schuurman et al., A cannabinoid mechanism in relapse to cocaine seeking, Nature Med, vol.7, pp.1099-1100, 2001.

J. Fowler, E. Gardner, and J. Brodie, A novel strategy for the treatment of cocaine addiction, Synapse, vol.30, pp.119-129, 1998.

P. Elliott and C. Nemeroff, Repeated neurotensin administration in the ventral tegmental area: Effects on baseline and d-amphetamine-induced locomotor activity, Neuroscience Letters, vol.68, issue.2, 1986.
DOI : 10.1016/0304-3940(86)90149-7

G. Ervin, L. Birkemo, C. Nemeroff, A. Prange, and . Jr, Neurotensin blocks certain amphetamine-induced behaviours, Nature, vol.10, issue.5810, pp.73-76, 1981.
DOI : 10.1038/291073a0

W. Fantegrossi, M. Ko, J. Woods, and E. Richelson, Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys, Pharmacology Biochemistry and Behavior, vol.80, issue.2, pp.341-349, 2005.
DOI : 10.1016/j.pbb.2004.12.005

M. Fatigati, R. Anderson, and R. , Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing, Brain Research, vol.876, issue.1-2, pp.196-200, 2000.
DOI : 10.1016/S0006-8993(00)02654-8

C. Ferrario, G. Gorny, H. Crombag, B. Kolb, and T. Robinson, Neural and Behavioral Plasticity Associated with the Transition from Controlled to Escalated Cocaine Use, Biological Psychiatry, vol.58, issue.9, pp.751-759, 2005.
DOI : 10.1016/j.biopsych.2005.04.046

A. Ford and C. Marsden, In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin andd-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat, Brain Research, vol.534, issue.1-2, pp.243-250, 1990.
DOI : 10.1016/0006-8993(90)90135-X

F. Gawin, Cocaine addiction: psychology and neurophysiology, Science, vol.251, issue.5001, pp.1580-1586, 1991.
DOI : 10.1126/science.2011738

F. Gawin, E. Ellinwood, and . Jr, Cocaine Dependence, Annual Review of Medicine, vol.40, issue.1, pp.149-161, 1989.
DOI : 10.1146/annurev.me.40.020189.001053

S. Geisler and D. Zahm, Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of their origins and [2] responses to acute psychostimulant and antipsychotic drug administration, European Journal of Neuroscience, vol.42, issue.1, pp.116-134, 2006.
DOI : 10.1111/j.1460-9568.2006.04928.x

S. Geisler, A. Bérod, D. Zahm, and W. Rostène, Brain neurotensin, psychostimulants, and stress ??? emphasis on neuroanatomical substrates, Peptides, vol.27, issue.10, pp.2364-2384, 2006.
DOI : 10.1016/j.peptides.2006.03.037

L. Gendron, A. Perron, M. Payet, N. Gallo-payet, P. Sarret et al., Low-Affinity Neurotensin Receptor (NTS2) Signaling: Internalization-Dependent Activation of Extracellular Signal-Regulated Kinases 1/2, Molecular Pharmacology, vol.66, issue.6, pp.1421-1430, 2004.
DOI : 10.1124/mol.104.002303

P. Glimcher, A. Govino, and B. Hoebel, Neurotensin self-injection in the ventral tegmental area, Brain Research, vol.403, issue.1, pp.147-150, 1987.
DOI : 10.1016/0006-8993(87)90134-X

P. Glimcher, D. Margolin, A. Giovino, and B. Hoebel, Neurotensin: A new ???reward peptide???, Brain Research, vol.291, issue.1, pp.119-124, 1984.
DOI : 10.1016/0006-8993(84)90657-7

B. Horger, J. Taylor, J. Elsworth, and R. Roth, Preexposure to, but Not Cotreatment with, the Neurotensin Antagonist SR 48692 Delays the Development of Cocaine Sensitization, Neuropsychopharmacology, vol.11, issue.3, pp.215-222, 1994.
DOI : 10.1038/sj.npp.1380108

J. Jaffe, N. Cascella, K. Kumor, and M. Scherer, Cocaine-induced cocaine craving, Psychopharmacology, vol.230, issue.4, pp.59-64, 1989.
DOI : 10.1007/BF00443414

P. Kalivas and P. Duffy, Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens, J Neurosci, vol.10, pp.2940-2949, 1990.

P. Kalivas and J. Stewart, Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity, Brain Research Reviews, vol.16, issue.3, pp.223-244, 1991.
DOI : 10.1016/0165-0173(91)90007-U

B. Kinkead and B. Nemeroff, Neurotensin: an endogenous antipsychotic?, Current Opinion in Pharmacology, vol.2, issue.1, pp.99-103, 2002.
DOI : 10.1016/S1471-4892(01)00128-X

P. Kitabgi, Targeting neurotensin receptors with agonists or antagonists for therapeutic purposes, Curr Opin Drug Discov Dev, vol.5, pp.764-776, 2002.

G. Koob, P. Sanna, and F. Bloom, Neuroscience of Addiction, Neuron, vol.21, issue.3, pp.467-476, 1998.
DOI : 10.1016/S0896-6273(00)80557-7

M. Kreek, K. Laforge, and E. Butelman, Pharmacotherapy of addictions, Nature Reviews Drug Discovery, vol.270, issue.9, pp.710-726, 2002.
DOI : 10.1016/S0376-8716(00)00162-9

M. Kuhar, M. Ritz, and J. Boja, The dopamine hypothesis of the reinforcing properties of cocaine, Trends in Neurosciences, vol.14, issue.7, pp.299-302, 1991.
DOI : 10.1016/0166-2236(91)90141-G

Y. Li, X. Hu, T. Berney, A. Vartanian, C. Stine et al., Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations, Synapse, vol.18, issue.3, pp.169-180, 1999.
DOI : 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C

Q. Liu, L. Pu, and M. Poo, Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons, Nature, vol.437, issue.7061, pp.1027-1031, 2005.
DOI : 10.1038/nature04050

H. Meltzer, L. Arvanitis, D. Bauer, W. Rein, and M. Group, Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder, American Journal of Psychiatry, vol.161, issue.6, pp.975-984, 2004.
DOI : 10.1176/appi.ajp.161.6.975

A. Morgan, S. Porter, F. Clarkson, N. Volkow, J. Fowler et al., Direct approach for attenuating cocaine's effects on extracellular dopamine: Targeting the dopamine transporter, Synapse, vol.10, issue.4, pp.423-427, 1997.
DOI : 10.1002/(SICI)1098-2396(199708)26:4<423::AID-SYN10>3.0.CO;2-U

D. Mueller and J. Stewart, Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction, Behavioural Brain Research, vol.115, issue.1, pp.39-47, 2000.
DOI : 10.1016/S0166-4328(00)00239-4

O. Brien, M. Anthony, and J. , Risk of Becoming Cocaine Dependent: Epidemiological Estimates for the United States, 2000???2001, Neuropsychopharmacology, vol.26, issue.5, pp.1006-1018, 2000.
DOI : 10.1038/sj.npp.1300681

F. Panayi, E. Dorso, L. Lambas-senas, B. Renaud, H. Scarna et al., Chronic Blockade of Neurotensin Receptors Strongly Reduces Sensitized, but Not Acute, Behavioral Response to D-amphetamine, Neuropsychopharmacology, vol.26, issue.1, pp.64-74, 2002.
DOI : 10.1016/S0893-133X(01)00354-2

R. Pierce and P. Kalivas, A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants, Brain Research Reviews, vol.25, issue.2, pp.192-216, 1997.
DOI : 10.1016/S0165-0173(97)00021-0

M. Pilla, S. Perachon, F. Sautel, F. Garrido, A. Mann et al., errata Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist, Nature, vol.400, issue.6751, pp.371-375, 1999.
DOI : 10.1038/43944

R. Post and H. Rose, Increasing effects of repetitive cocaine administration in the rat, Nature, vol.132, issue.5553, pp.731-732, 1976.
DOI : 10.1038/260731a0

F. Radja, P. Bauco, and P. Rompré, Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3]neurotensin binding sites within the ventral midbrain and striatum, European Journal of Pharmacology, vol.539, issue.3, pp.158-163, 2006.
DOI : 10.1016/j.ejphar.2006.03.060

E. Richelson, M. Boules, and P. Fredrickson, Neurotensin agonists: possible drugs for treatment of psychostimulant abuse, Life Sciences, vol.73, issue.6, pp.679-690, 2003.
DOI : 10.1016/S0024-3205(03)00388-6

T. Robinson and K. Berridge, The neural basis of drug craving: An incentive-sensitization theory of addiction, Brain Research Reviews, vol.18, issue.3, pp.247-291, 1993.
DOI : 10.1016/0165-0173(93)90013-P

P. Rompré, Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine, European Journal of Pharmacology, vol.328, issue.2-3, pp.131-134, 1997.
DOI : 10.1016/S0014-2999(97)00159-3

P. Rompré and P. Bauco, Neurotensin receptor activation sensitizes to the locomotor stimulant effect of cocaine: A role for NMDA receptors, Brain Research, vol.1085, issue.1, pp.77-86, 2006.
DOI : 10.1016/j.brainres.2006.02.011

P. Rompré, S. Boye, and J. Moisan, Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing, European Journal of Pharmacology, vol.341, issue.2-3, pp.169-172, 1998.
DOI : 10.1016/S0014-2999(97)01475-1

P. Rompré and S. Perron, Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization, Neuropharmacology, vol.39, issue.10, pp.1880-1892, 2000.
DOI : 10.1016/S0028-3908(99)00269-5

W. Rostène, M. Azzi, H. Boudin, I. Lépée, F. Souazé et al., Use of Nonpeptide Antagonists to Explore the Physiological Roles of Neurotensin., Annals of the New York Academy of Sciences, vol.264, issue.12, pp.125-140, 1998.
DOI : 10.1016/0006-2952(91)90229-X

D. Saal, Y. Dong, A. Bonci, and R. Malenka, Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons, Neuron, vol.37, issue.4, pp.577-582, 2003.
DOI : 10.1016/S0896-6273(03)00021-7

V. Santucci, C. Gueudet, R. Steinberg, L. Fur, G. Soubrié et al., Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade, Synapse, vol.221, issue.4, pp.370-380, 1997.
DOI : 10.1002/(SICI)1098-2396(199708)26:4<370::AID-SYN5>3.0.CO;2-3

Z. Sarnyai, . Shahamy, and S. Heinrichs, The role of corticotropin-releasing factor in drug addiction, Pharmacol Rev, vol.53, pp.209-243, 2001.

B. Soares, A. Reisser, and M. Farrell, Dopamine agonists for cocaine dependence, 2003.
DOI : 10.1002/14651858.cd003352.pub2

I. Sora, F. Hall, A. Andrews, M. Itokawa, X. Li et al., Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference, Proceedings of the National Academy of Sciences, vol.98, issue.9, pp.5300-5305, 2001.
DOI : 10.1073/pnas.091039298

M. Chagny, Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study, Neuroscience, vol.85, pp.1173-1182, 1998.

J. Stewart, Pathways to relapse: the neurobiology of drug-and stress-induced relapse to drug-taking, J Psychiatry Neurosci, vol.25, pp.125-136, 2000.

O. Valverde, C. Smadja, B. Roques, and R. Maldonado, The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCK B receptor antagonist, Psychopharmacology, vol.131, issue.1, pp.79-85, 1997.
DOI : 10.1007/s002130050268

W. Van-den-brink and . Van-ree, Pharmacological treatments for heroin and cocaine addiction, European Neuropsychopharmacology, vol.13, issue.6, pp.476-487, 2003.
DOI : 10.1016/j.euroneuro.2003.08.008

L. Vanderschuren and P. Kalivas, Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies, Psychopharmacology, vol.151, issue.2-3, pp.99-120, 2000.
DOI : 10.1007/s002130000493

P. Vezina, D. Lorrain, G. Arnold, J. Austin, and N. Suto, Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine, J Neurosci, vol.22, pp.4654-4662, 2002.

M. Yamada, M. Yamada, A. Lombet, P. Forgez, and W. Rostene, Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells, Life Sciences, vol.62, issue.23, pp.375-80, 1998.
DOI : 10.1016/S0024-3205(98)00192-1